• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.

作者信息

Cappellari Manuel, Forlivesi Stefano, Squintani Giovanna Maddalena, Facchinetti Roberto, Bovi Paolo

机构信息

USD Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata, Piazzale A. Stefani 1, 37126, Verona, Italy.

Laboratorio Analisi, DAI Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

出版信息

J Thromb Thrombolysis. 2017 May;43(4):528-529. doi: 10.1007/s11239-017-1485-1.

DOI:10.1007/s11239-017-1485-1
PMID:28214949
Abstract
摘要

相似文献

1
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update.使用依达赛珠单抗逆转达比加群后进行静脉溶栓治疗卒中：最新进展
J Thromb Thrombolysis. 2017 May;43(4):528-529. doi: 10.1007/s11239-017-1485-1.
2
Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.使用依达赛珠单抗急性逆转达比加群以进行静脉溶栓作为急性卒中治疗
J Clin Neurosci. 2019 Jan;59:355-357. doi: 10.1016/j.jocn.2018.09.027. Epub 2018 Oct 9.
3
[Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke].[急性缺血性卒中患者接受艾达司珠单抗治疗后进行全身溶栓]
Ideggyogy Sz. 2017 Jul 30;70(7-8):284-288. doi: 10.18071/isz.70.0284.
4
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.使用依达赛珠单抗逆转达比加群抗凝后成功进行缺血性卒中的静脉溶栓治疗：一例报告
J Med Case Rep. 2017 Aug 15;11(1):224. doi: 10.1186/s13256-017-1404-2.
5
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.达比加群效应经艾达赛珠单抗逆转后急性缺血性卒中的静脉溶栓治疗：台湾地区病例分析
J Stroke Cerebrovasc Dis. 2019 Mar;28(3):815-820. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.029. Epub 2018 Dec 17.
6
Acute stroke thrombolysis following dabigatran reversal using idarucizumab.使用艾达司珠单抗逆转达比加群后进行急性卒中溶栓治疗。
Neurol India. 2019 Mar-Apr;67(2):568-570. doi: 10.4103/0028-3886.258032.
7
Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.idarucizumab 逆转达比加群的作用：4 例急性脑卒中患者的单中心经验。
J Thromb Thrombolysis. 2018 Jul;46(1):12-15. doi: 10.1007/s11239-018-1658-6.
8
Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.达比加群经艾达西珠单抗逆转后静脉注射阿替普酶治疗急性缺血性卒中：病例报告
J Neurosci Nurs. 2019 Feb;51(1):21-25. doi: 10.1097/JNN.0000000000000412.
9
Idarucizumab elimination of dabigatran minutes before systemic thrombolysis in acute ischemic stroke.在急性缺血性卒中全身溶栓前几分钟使用艾达司珠单抗清除达比加群。
J Neurol Sci. 2016 Nov 15;370:44. doi: 10.1016/j.jns.2016.09.010. Epub 2016 Sep 9.
10
Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.在使用艾达赛珠单抗拮抗后，对正在接受达比加群抗凝治疗的中风患者进行重组组织型纤溶酶原激活剂静脉溶栓治疗。
Stroke. 2016 Jul;47(7):1936-8. doi: 10.1161/STROKEAHA.116.013550. Epub 2016 Jun 14.

引用本文的文献

1
Intravenous Thrombolysis After Dabigatran Reversal by Idarucizumab: A Systematic Review of the Literature.依达赛珠单抗逆转达比加群后的静脉溶栓治疗：文献系统评价
Front Neurol. 2021 Jun 3;12:666086. doi: 10.3389/fneur.2021.666086. eCollection 2021.
2
Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.急性缺血性脑卒中静脉溶栓治疗延误的因素：文献系统评价。
J Neurol. 2021 Aug;268(8):2723-2734. doi: 10.1007/s00415-020-09803-6. Epub 2020 Mar 21.
3
Thrombolysis in Acute Ischemic Stroke after Idarucizumab for Dabigatran Etexilate Reversal in Elderly: A Case Report.

本文引用的文献

1
Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.更新的欧洲心脏节律协会实用指南：非维生素 K 拮抗剂抗凝剂在非瓣膜性心房颤动患者中的应用：执行摘要。
Eur Heart J. 2017 Jul 14;38(27):2137-2149. doi: 10.1093/eurheartj/ehw058.
2
Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants.接受非维生素K拮抗剂口服抗凝剂治疗的患者行血管内血栓切除术的安全性
Stroke. 2016 Apr;47(4):1127-30. doi: 10.1161/STROKEAHA.116.012684. Epub 2016 Mar 1.
3
Idarucizumab: The Antidote for Reversal of Dabigatran.
依达赛珠单抗逆转达比加群酯抗凝作用后老年急性缺血性卒中的溶栓治疗：一例报告
J Vasc Interv Neurol. 2018 Nov;10(2):15-17.
4
Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations.日本抗凝患者卒中溶栓共识指南：对其他人群的应用
J Stroke. 2018 Sep;20(3):321-331. doi: 10.5853/jos.2018.01788. Epub 2018 Sep 30.
5
Evidence for Idarucizumab (Praxbind) in the Reversal Of the Direct Thrombin Inhibitor Dabigatran: Review Following the RE-VERSE AD Full Cohort Analysis.艾达赛珠单抗（Praxbind）逆转直接凝血酶抑制剂达比加群作用的证据：RE-VERSE AD全队列分析后的综述
P T. 2017 Nov;42(11):692-698.
6
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.达比加群酯治疗的急性缺血性脑卒中患者应用依达鲁单抗溶栓：现有证据的系统评价。
CNS Drugs. 2017 Sep;31(9):747-757. doi: 10.1007/s40263-017-0460-x.
艾达司珠单抗：达比加群逆转的解毒剂。
Circulation. 2015 Dec 22;132(25):2412-22. doi: 10.1161/CIRCULATIONAHA.115.019628.
4
Idarucizumab for Dabigatran Reversal.达比加群酯逆转剂依达鲁珠单抗。
N Engl J Med. 2015 Aug 6;373(6):511-20. doi: 10.1056/NEJMoa1502000. Epub 2015 Jun 22.
5
Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.非维生素K拮抗剂口服抗凝剂使用者卒中的静脉溶栓治疗：最新进展
Thromb Haemost. 2015 Aug;114(2):440-4. doi: 10.1160/TH14-11-0973. Epub 2015 Mar 26.